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Abstract
OBJECTIVE—To assess the quality of tuberculosis (TB) surveillance in Haiti, including whether 
underreporting from facilities to the national level contributes to low national case registration.
METHODS—We collected 2010 and 2012 TB case totals, reviewed laboratory registries, and 
abstracted individual TB case reports from 32 of 263 anti-tuberculosis treatment facilities 
randomly selected after stratification/weighting toward higher-volume facilities. We compared site 
results to national databases maintained by a non-governmental organization partner (International 
Child Care [ICC]) for 2010 and 2012, and the National TB Program (Programme National de 
Lutte contre la Tuberculose, PNLT) for 2012 only.
RESULTS—Case registries were available at 30/32 facilities for 2010 and all 32 for 2012. Totals 
of 3711 (2010) and 4143 (2012) cases were reported at the facilities. Case totals per site were 
higher in site registries than in the national databases by 361 (9.7%) (ICC 2010), 28 (0.8%) (ICC 
2012), and 31 (0.8%) cases (PNLT 2012). Of abstracted individual cases, respectively 11.8% and 
6.8% were not recorded in national databases for 2010 (n = 323) and 2012 (n = 351).
CONCLUSIONS—The evaluation demonstrated an improvement in reporting registered TB 
cases to the PNLT in Haiti between 2010 and 2012. Further improvement in case notification will 
require enhanced case detection and diagnosis.
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TUBERCULOSIS (TB) is a serious public health problem in Haiti; disease rates are the 
highest in the Western hemisphere,1 and TB has been reported among the leading causes of 
death.2 Between 2005 and 2011, the Haitian National TB Program (Programme National de 
Lutte contre la Tuberculose, PNLT) consistently reported approximately 14 000 cases each 
year. Case detection coverage was thought to be incomplete, however, as during this time 
the World Health Organization (WHO) estimates of the annual numbers of incident cases 
ranged from 22 000 to 27 200.1 The true prevalence and potential causes of under-detection 
are poorly understood. Prevalence surveys, capture/recapture studies, and review of vital 
records can inform estimates of case-detection rates, but these have not been implemented in 
Haiti.
The PNLT has conducted TB surveillance since the late 1980s. As of mid-2013, there were 
233 diagnostic and treatment centers (Centres de Diagnostique et de Traitement, CDT) and 
30 treatment centers (Centres de Traitement, CT) registering patients for treatment across 
Haiti’s 10 administrative departments.3 Several paper-based registries are used for data 
collection at the site level, including TB case, laboratory, contact tracing, and respiratory 
symptomatic registries. In 1997, International Child Care (ICC), a local non-governmental 
organization (NGO) partnering with the PNLT, established a nationallevel surveillance 
database containing individual case report data. In 2011, the PNLT established a separate 
case-based database, and both databases are currently being maintained during a period of 
transition from ICC to the PNLT. Data collection methods vary by region and by database. 
While ICC manually duplicates case registries to collect data at the site level, PNLT staff 
obtain photocopies of TB case registers during quarterly departmental meetings. Data entry 
and cleaning for both databases are performed at the central level, in Port-au-Prince, Haiti. 
During the quarterly department meetings, program and site-level data are reviewed and 
aggregate data reports are generated.
To evaluate accuracy and completeness of reporting, and to determine if underreporting 
from facilities to the national level contributes to low national case registration, we 
evaluated TB surveillance in Haiti using a nationally representative sample of TB cases 
reported by the PNLT.
METHODS
From February to May 2013, we conducted an evaluation of the TB surveillance system in 
Haiti. We used adapted versions of WHO and Global Fund (Geneva, Switzerland) tools, 
including the TB Information System Assessment Tool (TISAT), the ‘Assessment of 
Surveillance Data Workbook’, and the Routine Data Quality Assessment (RDQA) tool4–6 to 
assess TB data abstracted from program-associated registries, patient cards, reports, and 
centralized databases. Data from year 2010 and 2012 were evaluated to allow both an 
examination of recent data and an assessment of reporting over time.
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Sample size and facility selection
We estimated the sample size required to assess the proportion of cases identified at either 
CDT or CT facilities that were included in 2011 national TB case databases (n = 276). Based 
on a conservative estimate that 50% of cases registered at facilities would be reported 
centrally, a precision estimate of ±4% and a design effect of 4, we calculated a target sample 
size of 2056 cases per year. Thirty facilities (Figure) were chosen at random after stratifying 
facilities by the number of annual cases seen and weighting toward larger facilities to ensure 
capture of the potential impact large facilities might have on reporting quality. The initial 
sample included facilities from eight of Haiti’s 10 departments; two additional larger 
facilities were randomly selected from the departments of Grande-Anse and Nippes so that 
at least one facility was assessed in each department.
Data collection and abstraction
At each facility, we obtained both aggregate tallies and patient-level data from the four 
available TB registries (TB case, laboratory, respiratory symptomatic, and contact tracing) 
for 2010 and 2012.
For the TB case registry, aggregate totals were tallied for all cases, acid-fast bacilli (AFB) 
smearpositive cases, AFB-negative cases, cases tested for human immunodeficiency virus 
(HIV) infection, HIVpositive cases, and treatment outcomes (cured, completed treatment, 
treatment failure, lost to follow-up, or died) for each facility by month. We compared these 
facility-level aggregate data to the corresponding aggregate facility data from the ICC 
database for 2010 and 2012, and from the PNLT database for 2012.
Patient data for the first TB case of each month were abstracted and compared to data on the 
same case from the TB laboratory registry, the patient treatment card, and the central 
databases. At sites where cases were not available each month, additional cases were 
abstracted to achieve a total of 12 cases.
The TB laboratory registry data were evaluated at each facility for 2012 only. We collected 
aggregate data on microscopy results from the initial diagnostic sputum specimens evaluated 
in 2012. During the evaluation, initial defaulters, defined as smear-positive TB patients not 
confirmed as starting treatment, were recorded from laboratory registers at facilities. After 
laboratory data had been abstracted at all facilities, the list of initial defaulters was compared 
with the central databases to determine if the patients were subsequently diagnosed with TB 
and initiated treatment at another facility.
The respiratory symptomatic registry was evaluated for years 2010 and 2012. Individual 
case data were aggregated by calendar month. The total number of cases evaluated was 
recorded, along with total numbers of patients with AFB-positive vs. AFBnegative results. 
All information from the first AFBpositive case listed each month in the 2012 respiratory 
symptomatic registry was abstracted and matched to the 2012 TB Case Registry to 
determine the proportion of individuals that initiated TB treatment at that facility.
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Data storage and analysis
All information was stored on secure databases. To facilitate comparison of individual case 
data to the national databases, names and other identifying information were used for 
comparisons between facility registries and the national databases. Weighted proportions 
were calculated by comparing total cases recorded at facilities to total cases captured within 
each database and weighting by total cases seen at each facility. These weighted means of 
the proportions were compared across years for significance (P < 0.5) using Student’s t-test 
and JMP®10 (SAS, version 9.3; Statistical Analysis System Institute, Cary, NC, USA).
The treatment success rate was defined as the number of cases who were cured or completed 
treatment divided by the total number of cases. Patients who were transferred, lost to follow-
up, or misdiagnosed were excluded from the total number of cases. Treatment success rates 
were calculated for both aggregate and abstracted individual TB case totals. Treatment 
success rates were weighted by total cases seen at each facility. For abstracted individual 
case data, this calculation was restricted to cases who were AFB-positive as described by the 
WHO calculation.7 To account for clustering and stratification of facilities, SAS complex 
survey procedures (SAS version 9.3) were used to calculate the 95% confidence intervals 
(CIs) and design effect for treatment success rates.
The Centers for Disease Control and Prevention (CDC) and the PNLT determined this 
project to be a public health program evaluation. Institutional Review Board (IRB) review 
was not required, as the activity did not constitute human subjects research. Informed 
consent was not required, as this evaluation of routinely collected surveillance data did not 
involve contact with human subjects and presented no risk to individuals whose records 
were reviewed.
RESULTS
TB case registries were available at 30 of 32 (93.8%) facilities for 2010 and all 32 facilities 
for 2012 (Table 1). Aggregated facility case totals were 3711 for 2010 and 4143 for 2012 for 
all available facilities. For 2010, case data had been entered into national databases for all 30 
evaluated facilities; for 2012, case data had been entered nationally for 30/32 facilities 
evaluated (with a facility case total of 3705) (Table 2). Case totals from facilities and the 
central database were compared for the same facilities. Based on these comparisons, 
aggregated case totals were higher in facility registries than in the ICC national database by 
361 (9.7%) (ICC 2010) and 28 (0.8%) (ICC 2012), and lower by 14 (0.4%) cases for the 
PNLT 2012 database (Table 2). The weighted means of the proportion of aggregated case 
data in agreement with central databases was 90.3% (95%CI 85.5–95.0) for the 2010 ICC 
database, 99.2% (95%CI 95.0–103.5) for the 2012 ICC database, and 99.3% (95%CI 94.74–
103.8) for the 2012 PNLT database. The increase in the weighted means of the proportions 
from 2010 to 2012 was statistically significant (P = 0.0058 for 2010 and 2012 ICC 
databases; P = 0.0046 for 2010 ICC and 2012 PNLT databases). Treatment success 
calculated from aggregate facility data was 84% (95%CI 77.1–90.5) for 2010 and 81% 
(95%CI 75.7–86.9) for 2012.
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For the abstracted individual cases, respectively 285/323 (88.2%), 327/351 (93.2%), and 
324/351 (92.3%) were recorded in the 2010 ICC, 2012 ICC, and 2012 PNLT national 
databases. Minimal duplication (0.3–1%) was observed in the databases (Table 3). Case-
level data from facilities differed from information in the 2010 ICC, 2012 ICC, and 2012 
PNLT national databases for 3.2%, 2.4% and 8.3% of AFB results and 12.3%, 7.3% and 8% 
of HIV test results, respectively (Table 3). These discrepancies reflected both missing data 
and the recording of results in the central database that differed from those recorded at the 
facilities. Final treatment determination for patients expected to have completed treatment 
was missing from the ICC database in 55.4% (2010) and 33.9% (2012) of cases, and was not 
available from the PNLT database at the time of the evaluation (Table 3). The weighted 
treatment success for AFB-positive cases was 88.5% (95%CI 84.1–93.0) in 2010 and 89.0% 
(95%CI 82.5–95.5) in 2012.
The laboratory register was available and complete at 27 (84.4%) facilities for 2010 and 31 
(96.8%) facilities for 2012 (Table 1). The results of diagnostic AFB samples were evaluated 
at 24/32 (75.0%) facilities, at which diagnostic samples were evaluated for 13 194 patients; 
1865 (14.1%) had at least two AFB-positive sputum samples and 9567 (72.5%) had negative 
results for all three sputum samples. Of the 1322 (10.0%) presumed TB cases who initiated 
but did not complete all three diagnostic sputum samples, 89 (0.7%) had initial AFB-
positive results. Patientidentifying information was collected at only 11 facilities for patients 
who did not provide all three initial diagnostic sputum samples. For these facilities, samples 
from 8826 patients were evaluated, of which 1377 (15.6%) had at least one positive sample. 
Of the 77 (5.6%) presumed TB cases who did not complete all three diagnostic AFB tests, 
10 (13.0%) were receiving treatment at another facility, according to information in the 2012 
ICC database.
The 2012 respiratory symptomatic registry was in use and complete or partially complete at 
24 of the 32 (75.0%) facilities evaluated (Table 1). Aggregate data were collected at the 11 
(45.8%) facilities using this register consistently; at these facilities, 621 (median 11.0%, 
range 4.4–35.1) of 3839 patients with symptoms had ≥2 positive smears. Selected cases 
from 20/24 (83.3%) facilities with available registries were abstracted and matched to the 
TB case registry. Of 140 AFB-positive cases evaluated, 22 (15.7%) were not found in the 
TB case registry at the facility.
DISCUSSION AND CONCLUSIONS
Our TB surveillance evaluation demonstrated a strongly performing system. Underreporting 
from the PNLT facilities to the national level does not appear to be an important reason for 
incomplete case notification in Haiti. Aggregated case totals seen at the facilities closely 
match database totals in 2012, and nearly all abstracted cases were found in the central 
databases.
Although there was generally good agreement between data from facility registers and data 
in the central databases, there were some important discrepancies related to sputum and HIV 
test results, and delays in entry of final treatment determinations limit the utility of the 
central databases for timely caselevel analysis of treatment outcomes. Completeness and 
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accuracy of data entry should be reinforced, particularly in the recording of HIV test results 
and treatment determination. Standard operating procedures could be developed to assist 
with this activity. Transition to electronic registries8 at selected facilities with existing 
capacity could improve linkage between different functions at the facilities and reduce data 
entry requirements at the national level.
There are potential missed diagnostic and followup opportunities with current sputum 
requirements. In accordance with current guidelines, improvements to TB surveillance could 
include verification that complete diagnostic evaluations are conducted for presumptive TB 
cases and allow for a smear-positive diagnosis based on a single sputum specimen to better 
capture smear-positive patients.9,10 Expanded use of the respiratory symptomatic and 
contact tracing registries could aid in TB case detection; however, further evaluation is 
needed to determine the effectiveness of these activities.
Although treatment outcomes were not a focus of this evaluation, our evaluation 
demonstrated more favorable outcomes than had been previously reported nationally in 
2010.1 The higher treatment success rates that we observed may reflect our weighting 
toward larger facilities, if outcomes are better at larger facilities.
This evaluation had several important limitations. Smaller facilities may be under-
represented because of our stratification. Abstracted cases from each facility may not be 
representative of all cases from the facilities or overall, and aggregate data from the selected 
facilities need to be interpreted with caution. This evaluation was focused on anti-
tuberculosis treatment facilities registered with the PNLT; while the evaluation would have 
missed patients receiving treatment at facilities not registered with the PNLT, this is thought 
to be rare, as anti-tuberculosis drugs in Haiti are only available through the PNLT.
Overall, the TB surveillance evaluation demonstrated improvement in reporting of registered 
TB to the PNLT in Haiti between 2010 and 2012. Further improvement in case notification 
will require improved case detection and diagnosis. Efforts should focus on finding persons 
with TB through complete diagnosis and expanded case-finding efforts. Active screening at 
health facilities and contact tracing are likely to be important approaches to improve case 
finding. While the yield of these efforts at the visited facilities varied, a more detailed 
evaluation might inform the prioritization and implementation of these activities.
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Tuberculosis evaluation sites selected in Haiti.
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Table 1










 2010 30 (93.8) — 2 (6.0)
 2012 32 (100.0) — —
TB laboratory registry
 2010 27 (84.4) 2 (6.3) 3 (9.4)
 2012 31 (96.9) — 1 (3.1)
Contact tracing registry
 2012 7 (21.9) 16 (50.0) 9 (28.1)
Respiratory symptomatic registry
 2010 6 (18.8) — 26 (81.3)
 2012 21 (65.6) 3 (9.4) 8 (25.0)
Patient cards
 2010 12 (37.5) 19 (59.4) 1 (3.1)
 2012 24 (75.0) 8 (25.0) —
*
TB case registries were missing at two facilities for 2010. One facility did not perform sputum-based diagnosis on site. TB = tuberculosis.
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Aggregated TB case totals
Site data ICC database PNLT database*
2010 case totals (n = 30 facilities) 3711 3350 —
 AFB-positive cases 2065 1865 —
 HIV-tested cases 2842 2355 —
 HIV-positive cases 615 520 —
 Cases cured 1582 1440 —
 Cases completing treatment 1115 1209 —
 Cases transferred 445 175 —
 Cases lacking treatment determination 37 37 —
 Patients misdiagnosed with TB 12 — —
2012 case totals (n = 30 facilities)
† 3705 3677 3719
 AFB-positive cases 2111 2051 1985
 HIV-tested cases 3346 3118 3123
 HIV-positive cases 769 724 697
 Cases cured 1179 772 —
 Cases completing treatment 974 660 —
 Cases transferred 190 116 —
 Cases lacking treatment determination 865 1143 3719
 Patients misdiagnosed with TB 3 — —
TB = tuberculosis; ICC = International Child Care; PNLT = Programme national de Lutte contre la Tuberculose; AFB = acid-fast bacilli; HIV = 
human immunodeficiency virus.
*
For the 2012 PNLT database, treatment completion information had not been entered at the time of the comparison.
†
Only 30 facility registries could be evaluated because ICC data from two facilities (Centre médico social de Gebeau and Hôpital Dumarsais 
Estime) had not been completely entered into the databases at the time of evaluation.
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Table 3
2010 and 2012 TB database evaluation using abstracted case data from 32 facilities in Haiti








Records found for comparison 285 (88.2) 327 (93.2) 324 (92.3)
Duplicates found 2 (0.6) 5 (1.4) 1 (0.3)
Database/TB case registry mismatches*
 Age 68 (23.9) 23 (7.0) 22 (6.8)
 Address 118 (41.4) 24 (7.3) 19 (5.9)
 Name 2 (0.7) 4 (1.2) 5 (1.5)
 Mother’s name — — 98 (30.2)
 Sex 5 (1.8) 5 (1.5) 6 (1.6)
 Type of TB (pulmonary vs. extra-pulmonary) 16 (5.6) 14 (4.3) 11 (3.4)
 Type of TB case (new vs. retreatment, etc.) 16 (5.6) 29 (8.9) 22 (6.8)
 Weight at initial examination 83 (29.1) 36 (11.0) 31 (9.6)
 Registration date — — 35 (10.8)
 Date of initial treatment 44 (15.4) 23 (7.0) —
  Difference <5 days 12 (27.3) 4 (17.4) —
 AFB date — — 270 (83.3)
  Difference <5 days — — 67 (24.8)
 AFB results 9 (3.2) 8 (2.4) 27 (8.3)
  Different result recorded 9 (100) 8 (100) 6 (22.2)
  Blank in database 0 21 (77.8)
 HIV tested 41 (14.4) 21 (6.4) 18 (5.6)
 HIV test date 84 (29.5) 62 (19.0) 61 (18.8)
  Difference <5 days 5 (6.0) 8 (12.9) 55 (90.2)
 HIV test results 35 (12.3) 24 (7.3) 26 (8.0)
  Different result recorded 20 (57.1) 4 (16.7) 3 (11.5)
  Blank in database 15 (42.9) 20 (83.3) 23 (88.5)
 Final treatment determination
† 158 (55.4) 111 (33.9) —
  Different treatment determination value recorded 26 (16.5) 14 (12.6) —
  Blank in database 132 (83.5) 97 (87.4) —
 Final treatment determination date
† 170 (59.6) 134 (41.0) —
  Different date recorded 20 (11.8) 34 (25.4) —
  Difference <5 days 9 (5.3) 5 (3.7) —
  Blank in database 150 (88.2) 100 (74.6) —
TB = tuberculosis; ICC = International Child Care; PNLT = Programme national de Lutte contre la Tuberculose; AFB = acid-fast bacilli; HIV = 
human immunodeficiency virus.
*
Where type of mismatch could be broken down further, the proportion of the total error was determined.
†
Final treatment determination was not evaluated in the PNLT database due to unavailability of these data for analysis.
Int J Tuberc Lung Dis. Author manuscript; available in PMC 2015 December 18.
